Xerox has been a core technology provider for the rapidly expanding data and marketing company since 2006, and this additional technology will allow the company to better meet its clients’ needs for faster turnaround times and color consistency.
“The iGen platform has been a great fit for our overall growth strategy. It gives us the flexibility to run our diverse product set with ease, while allowing us to quickly add capacity when needed,” said Tim Graham, President and COO, OTC Group. “Whether we’re printing direct mail, personalized food packaging or serialized pharmaceutical cartons, we have the confidence that we’ll deliver the quality that each job demands.”
The Xerox iGen 5 printing presses, with 24 pt capability, will produce pharmaceutical cartons serving OTC’s Brand Protection process, which extends the supply chain view to end users and consumers.
OTC Brand Protection provides powerful consumer data back to the product manufacturer to be used for marketing or regulatory requirements. The process integrates with a client’s current serialization scheme and does not require material change to the manufacturer’s supply chain network.
The new printing presses will be installed at the firm’s locations in London, Ontario and in Port Huron, Michigan.
“OTC Group has an amazing way of looking beyond the horizon at applications that will become significant opportunities in this marketplace,” said Brad King, Vice President, Graphic Communications Operations, Xerox Canada. “This type of thinking opens up new avenues of revenue and client value, and we’re proud that OTC Group chooses Xerox technology and workflow solutions to enable production of their cutting-edge ideas and offerings.”
The Xerox iGen 5 complements the existing offerings within the iGen family – the Xerox® iGen® 150 and the Xerox® iGen4® Diamond Edition – by continuing to expand the scope of applications that can be produced using Xerox’s industry-leading production color portfolio. Click for more information.